• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[CA-50 in serum of patients with carcinoma. Clinical experiences with a new tumor marker].

作者信息

Bruhn H D, Broers H, Euler H, Everding A, Feller A C, Hedderich J, Jostarndt L, Jooss B, Zurborn K H, Löffler H

出版信息

Dtsch Med Wochenschr. 1986 Aug 22;111(34):1267-72. doi: 10.1055/s-2008-1068617.

DOI:10.1055/s-2008-1068617
PMID:3461933
Abstract

Quantitative radioimmunological demonstration of carbohydrate antigen CA-50 in serum achieved a sensitivity of 62.3% for colorectal carcinoma (n = 53), of 64.7% for gastric carcinoma (n = 34), of 33.9% for lung carcinoma (n = 56), and 19.8% for lymphoproliferative diseases (n = 91). The positive results for the latter probably correspond to the immunohistological demonstration of the antigen in dendritic reticulum cells. Occasionally an increased CA-50 level in inflammatory disease presents difficulties in differential diagnosis, but it returns to normal when the inflammatory process has subsided. Methodological scatter of the CA-50 system is satisfactory, with a coefficient of variation of +/- 11%, but unsatisfactory at low values (less than or equal to 10 U/ml) and high ones (greater than or equal to 50 U/ml) with a coefficient of variation of +/- 19%. Further development with the IMRA technique may significantly reduce methodological scatter (coefficient of variation +/- 5%).

摘要

相似文献

1
[CA-50 in serum of patients with carcinoma. Clinical experiences with a new tumor marker].
Dtsch Med Wochenschr. 1986 Aug 22;111(34):1267-72. doi: 10.1055/s-2008-1068617.
2
Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.与癌胚抗原(CEA)和糖类抗原19-9(Ca 19-9)相比,评估糖类抗原12-5(Ca 12-5)作为胃癌和结直肠癌肿瘤标志物的情况。
Eur J Surg Oncol. 1987 Jun;13(3):197-201.
3
[Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].[血清糖类抗原19-9测定在胃癌及结直肠癌患者中的临床意义]
Gan No Rinsho. 1985 Aug;31(10):1287-92.
4
[Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].[肿瘤标志物CA 19-9与癌胚抗原(CEA)在手术前后诊断中的临床评估比较]
Nuklearmedizin. 1986 Feb;25(1):9-14.
5
[Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].[4种血清标志物联合检测在各类恶性肿瘤中的优势与局限性]
Minerva Med. 1986 Sep 15;77(34-35):1521-5.
6
[Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
Med Klin (Munich). 1986 Mar 18;81(6):199-201.
7
[Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].血清糖类抗原(CA)19-9检测在胃癌诊断中的应用
Gan To Kagaku Ryoho. 1986 Jan;13(1):101-8.
8
[Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
Dtsch Med Wochenschr. 1984 Aug 31;109(35):1309-12. doi: 10.1055/s-2008-1069368.
9
[Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
Nihon Gan Chiryo Gakkai Shi. 1986 Jun 20;21(5):969-77.
10
The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
Fukushima J Med Sci. 1985 Jun;31(1):29-42.

引用本文的文献

1
A clinical study of CA-50 as a tumour marker for monitoring of colorectal cancer.
Med Oncol Tumor Pharmacother. 1988;5(3):165-71. doi: 10.1007/BF02986440.